- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Hyderabad based CDMO company that offers services to leading global pharmaceutical and fine chemical majors in their NCE development endeavours. From process research & development to late-stage clinical and commercial manufacturing we are committed to provide customers with products fulfilling customer needs and expectations.
Cohance Lifesciences' committee has approved strategic investments totaling USD 18 million to strengthen its Antibody-drug Conjugate (ADC) strategy. The company will acquire additional shares in its subsidiary NJ Bio for approximately USD 13 million, increasing its stake from 56% to 67.3%. This aims for closer integration of NJ Bio’s services...